Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Erlotinib has tumor inhibitory effect in human retinoblastoma cells.

Shao Y, Yu Y, Zong R, Quyang L, He H, Zhou Q, Pei C.

Biomed Pharmacother. 2017 Jan;85:479-485. doi: 10.1016/j.biopha.2016.11.054. Epub 2016 Nov 26.

PMID:
27899256
2.

Basic fibroblast growth factor impact on retinoblastoma progression and survival.

Cebulla CM, Jockovich ME, Piña Y, Boutrid H, Alegret A, Kulak A, Hackam AS, Bhattacharya SK, Feuer WJ, Murray TG.

Invest Ophthalmol Vis Sci. 2008 Dec;49(12):5215-21. doi: 10.1167/iovs.07-1668. Epub 2008 Jul 9.

3.

Quinoline-Based Compound BPIQ Exerts Anti-Proliferative Effects on Human Retinoblastoma Cells via Modulating Intracellular Reactive Oxygen Species.

Cheng KC, Hung CT, Chen KJ, Wu WC, Suen JL, Chang CH, Lu CY, Tseng CH, Chen YL, Chiu CC.

Arch Immunol Ther Exp (Warsz). 2016 Apr;64(2):139-47. doi: 10.1007/s00005-015-0368-4. Epub 2015 Nov 12.

PMID:
26564153
4.

Phenoxazine derivative, 2-amino-4,4alpha-dihydro-4alpha,7-dimethyl-3H-phenoxazine-3-one suppresses growth of human retinoblastoma cell line Y79 in vitro and in vivo.

Kimura K, Usui Y, Hattori T, Yamakawa N, Goto H, Usui M, Okada S, Shirato K, Tomoda A.

Oncol Rep. 2008 Jan;19(1):3-10.

PMID:
18097569
5.

Effects of PPARγ agonistrosiglitazone on human retinoblastoma cell in vitro and in vivo.

Cao X, He L, Li Y.

Int J Clin Exp Pathol. 2015 Oct 1;8(10):12549-56. eCollection 2015.

6.

Amiloride sensitizes human pancreatic cancer cells to erlotinib in vitro through inhibition of the PI3K/AKT signaling pathway.

Zheng YT, Yang HY, Li T, Zhao B, Shao TF, Xiang XQ, Cai WM.

Acta Pharmacol Sin. 2015 May;36(5):614-26. doi: 10.1038/aps.2015.4. Epub 2015 Apr 13.

7.

Inhibition of Rb and mTOR signaling associates with synergistic anticancer effect of palbociclib and erlotinib in glioblastoma cells.

Liu S, Tang Y, Yuan X, Yuan D, Liu J, Li B, Li Y.

Invest New Drugs. 2018 Dec;36(6):961-969. doi: 10.1007/s10637-018-0575-z. Epub 2018 Mar 6.

PMID:
29508248
8.

Synergistic Effect of Curcumin in Combination with Anticancer Agents in Human Retinoblastoma Cancer Cell Lines.

Sreenivasan S, Krishnakumar S.

Curr Eye Res. 2015;40(11):1153-65. doi: 10.3109/02713683.2014.987870. Epub 2014 Dec 11.

PMID:
25495096
9.

Effect of the molecular targeted drug, erlotinib, against endometrial cancer expressing high levels of epidermal growth factor receptor.

Nishimura T, Nakamura K, Yamashita S, Ikeda S, Kigure K, Minegishi T.

BMC Cancer. 2015 Dec 16;15:957. doi: 10.1186/s12885-015-1975-5.

10.

Chemosensitization to adriamycin by cyclosporin A and verapamil in human retinoblastoma cell lines.

Lee TW, Yang SW, Kim CM, Hong WS, Youn DH.

J Korean Med Sci. 1993 Apr;8(2):104-9.

11.

Cotargeting of epidermal growth factor receptor and PI3K overcomes PI3K-Akt oncogenic dependence in pancreatic ductal adenocarcinoma.

Wong MH, Xue A, Julovi SM, Pavlakis N, Samra JS, Hugh TJ, Gill AJ, Peters L, Baxter RC, Smith RC.

Clin Cancer Res. 2014 Aug 1;20(15):4047-58. doi: 10.1158/1078-0432.CCR-13-3377. Epub 2014 Jun 3.

12.

Cytokine induced apoptosis in human retinoblastoma cells.

Cullinan AE, Brandt CR.

Mol Vis. 2004 Apr 22;10:315-22.

13.

Antiproliferative and apoptotic effects of indomethacin on human retinoblastoma cell line Y79 and the involvement of β-catenin, nuclear factor-κB and Akt signaling pathways.

Zheng Q, Zhang Y, Ren Y, Wu Y, Yang S, Zhang Y, Chen H, Li W, Zhu Y.

Ophthalmic Res. 2014;51(2):109-15. doi: 10.1159/000355844. Epub 2013 Dec 19.

PMID:
24355977
14.

Antitumor activity of celastrol nanoparticles in a xenograft retinoblastoma tumor model.

Li Z, Wu X, Li J, Yao L, Sun L, Shi Y, Zhang W, Lin J, Liang D, Li Y.

Int J Nanomedicine. 2012;7:2389-98. doi: 10.2147/IJN.S29945. Epub 2012 May 9.

15.

Differential microRNA-34a expression and tumor suppressor function in retinoblastoma cells.

Dalgard CL, Gonzalez M, deNiro JE, O'Brien JM.

Invest Ophthalmol Vis Sci. 2009 Oct;50(10):4542-51. doi: 10.1167/iovs.09-3520. Epub 2009 May 14.

PMID:
19443717
16.

Effect of curcumin on miRNA expression in human Y79 retinoblastoma cells.

Sreenivasan S, Thirumalai K, Danda R, Krishnakumar S.

Curr Eye Res. 2012 May;37(5):421-8. doi: 10.3109/02713683.2011.647224.

PMID:
22510010
17.

The effect of imatinib mesylate on the proliferation, invasive ability, and radiosensitivity of retinoblastoma cell lines.

de Moura LR, Marshall JC, Di Cesare S, Fernandes BF, Antecka E, Burnier MN.

Eye (Lond). 2013 Jan;27(1):92-9. doi: 10.1038/eye.2012.231. Epub 2012 Nov 16.

18.

Inhibition of MMP-2 and MMP-9 decreases cellular migration, and angiogenesis in in vitro models of retinoblastoma.

Webb AH, Gao BT, Goldsmith ZK, Irvine AS, Saleh N, Lee RP, Lendermon JB, Bheemreddy R, Zhang Q, Brennan RC, Johnson D, Steinle JJ, Wilson MW, Morales-Tirado VM.

BMC Cancer. 2017 Jun 20;17(1):434. doi: 10.1186/s12885-017-3418-y.

19.

Long noncoding RNA BDNF-AS is a potential biomarker and regulates cancer development in human retinoblastoma.

Shang W, Yang Y, Zhang J, Wu Q.

Biochem Biophys Res Commun. 2018 Mar 18;497(4):1142-1148. doi: 10.1016/j.bbrc.2017.01.134. Epub 2017 Jan 26.

PMID:
28131827
20.

Combining EGFR and mTOR blockade for the treatment of epithelioid sarcoma.

Xie X, Ghadimi MP, Young ED, Belousov R, Zhu QS, Liu J, Lopez G, Colombo C, Peng T, Reynoso D, Hornick JL, Lazar AJ, Lev D.

Clin Cancer Res. 2011 Sep 15;17(18):5901-12. doi: 10.1158/1078-0432.CCR-11-0660. Epub 2011 Aug 5.

Supplemental Content

Support Center